Loading...

ASHG 2010 Mtg.: "An Overview of the Emerging Field of Translational Genomics" (Dr. James Evans)

258 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Mar 25, 2011

TO VIEW THE FULL WEBCAST OF THIS SESSION, GO TO:
http://www.ashg.org/2010meeting/video...

ASHG 2010 Annual Meeting Concurrent Invited Session II: "The REVEAL Study at 10 Years: Lessons for Genetic Risk Disclosure and Personal Genomics"
Speaker: Dr. James P. Evans, University of North Carolina at Chapel Hill
November 4, 2010 (Washington, DC)

DESCRIPTION: There are concerns whether genetic susceptibility risk information can be properly communicated and whether it is ethical to provide that information to those who seek it. The REVEAL Study, funded in 1999, was the world's first randomized controlled trial to examine the effects of providing genetic susceptibility testing and Alzheimer's disease (AD) risk assessment to adult children of people with AD. Since then, it has continued as a series of multi-site randomized controlled trials that empirically examines translational issues in genetic susceptibility testing for common diseases. In this session, we provide the most pertinent results from the REVEAL Study including the emotional impact of receiving genetic susceptibility information for AD, understanding of the information and risk recall, insurance purchasing behaviors and health behavior changes. Additionally, we will discuss the direct implications to the emergence of personal genomics and explore the current and future ethical, legal and social issues.

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...